Early detection of cancer improves survival and lowers medical costs. MiRXES is committed to enable cancer detection at asymptomatic and actionable stage through blood based screening. MiRXES leverages an ultra-sensitive qPCR technology to detect blood borne miRNA cancer markers to deliver the solution.
MiRXES welcomes collaboration in clinical validation of cancer miRNA assaysContact Us
We empower miRNA research with tailored products and servicesRead More
We seek passionate and committed individuals to realize our visionHiring Now
MiRXES Welcomes investors and strategic partners to accelerate growthRead More